⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 15, 2006HypertensionOpen Access

Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat

View Full Paper

Ask AI

Bookmark

Share

Authors

MOMaría Paz OcaranzaPontificia Universidad Católica de Chile IGIván GodoyInstituto Nacional de Tecnologia JJJorge JalilPontificia Universidad Católica de Chile

Discussion

Loading...

Member takes

Implication

Rat MI model shows ACE/ACE2 shifts; hypothesis-generating and leaves open human translation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ocaranza et al. (2006) studied this question.

synapsesocial.com/papers/6a7fe5e5bae189c53c6c7147 https://doi.org/10.1161/01.hyp.0000237862.94083.45

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse2003 · 36 citations
2Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors2004 · 575 citations
3Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 22005 · 1,617 citations
4Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.1994 · 422 citations
5Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation2004 · 90 citations